Actively Recruiting
Developmental Dysplasia of the Hip: Observation vs. Bracing
Led by University of British Columbia · Updated on 2025-11-24
514
Participants Needed
1
Research Sites
227 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Developmental dysplasia of the hip (DDH) is the most common childhood hip condition. When caught early, bracing is the most frequently used treatment; however, the brace can disrupt important mother-baby bonding time in the newborn period and present challenges to daily living. In babies with mild DDH, some studies have suggested that their hips may improve naturally as they grow and develop. This study will look at whether careful monitoring can be just as good as bracing for babies diagnosed with mild DDH less than 3 months of age, potentially avoiding unnecessary treatment. This will be the first study to look at this question with babies being treated at different hospitals in seven different countries, so the results will make an impact on children and families worldwide.
CONDITIONS
Official Title
Developmental Dysplasia of the Hip: Observation vs. Bracing
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients presenting with radiological dysplasia of a clinically stable hip under three months (12 weeks) of age
- Radiological dysplasia defined as a centred hip with an alpha angle between 43 and 60 degrees and femoral head coverage greater than 35% on ultrasound exam
You will not qualify if you...
- Patients older than three months (12 weeks) at presentation
- Patients with clinical hip instability (Ortolani or Barlow positive)
- Patients with known or suspected neuromuscular, collagen, chromosomal, or lower-extremity congenital abnormalities or syndromic-associated hip abnormalities
- Patients who received prior treatment (e.g., Pavlik harness) for DDH
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
BC Children's Hospital
Vancouver, British Columbia, Canada, V6H3N1
Actively Recruiting
Research Team
E
Emily Schaeffer, PhD
CONTACT
B
Bryn Zomar, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here